Description
🔴+ Include: 19 videos, size: 4 GB
👩🏼💻🧑🏾💻 + Target Audience: nuclear medicine physicians, technologists, radiologists, neurologists, oncologists, cardiologists, endocrinologists, rheumatologists
🔴 + Information:
📆 Release date: October 4, 2024
Advances in Nuclear Medicine and Molecular Imaging features fourteen internationally renowned faculty experts discussing nuclear medicine’s latest trends and emerging procedures. Created from the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging’s 52nd Annual Conference, this activity presents the impact of radiopharmaceuticals on imaging, cardiology, oncology, and much more. Robust discussions of imaging tools, administration equipment, dosimetry, and future applications are included, as well. Advances in Nuclear Medicine and Molecular Imaging meet Nuclear Medicine/PET accreditation requirements and provide an essential update for all physicians and technologists involved with this area of medicine.
Topics include: Cardiac applications, myocardial imaging, dosimetry, theranostics, radiotracer-based bone scanning, lymphoma staging, PET applications for glioblastoma, thyroid cancer, and prostate cancer, SPECT-CT, radiation safety, artificial intelligence, emerging radiopharmaceuticals, and much more.
The target audience for the Meetings By Mail 52nd Annual Nuclear Medicine & Molecular Imaging Update 2024 includes: nuclear medicine physicians, technologists, radiologists, neurologists, oncologists, cardiologists, endocrinologists, rheumatologists, and other medical professionals who use radionuclides in patient care. This update provides a comprehensive refresher on the latest trends, advances, and procedures in nuclear medicine and molecular imaging.
📌+ Topics:
✅Session 1 Advances in Nuclear Medicine & Molecular Imaging Developing a PET-CT RB-82 Myocardial Imaging Program.mp4
✅Session 1 Advances in Nuclear Medicine & Molecular Imaging Molecular Imaging With PET to Detect and Quantify Atherosclerotic Plaques.mp4
✅Session 1 Advances in Nuclear Medicine & Molecular Imaging Rb-82 PET Myocardial Blood Flow Imaging.mp4
✅Session 2 Dosimetry Advanced Dosimetry Including Use in the Theranostics Routine.mp4
✅Session 2 Dosimetry Dosimetry Basics.mp4
✅Session 2 Dosimetry Personalized dosimetry for Y90 TARE.mp4
✅Session 3 Oncologic Imaging: Can Radiotracer-Based Bone Scanning Detect Metastasis Survive the Test of Time.mp4
✅Session 3 Oncologic Imaging Lymphoma Staging and Response Assessment Past, Present and Future.mp4
✅Session 3 Oncologic Imaging PET CT in Brain Tumors Current and Potential Future Applications.mp4
✅Session 3 Oncologic Imaging Recent Developments and Issues in Differentiated Thyroid Cancer.mp4
✅Session 3 Oncologic Imaging Systemic Therapy in Advanced Prostate Cancer The Evolving Landscape.mp4
✅Session 4 Radiation Safety & SPECT-CT Benefits of SPECT-CT.mp4
✅Session 4 Radiation Safety & SPECT-CT Our Quest for Ultra Low Dose PET-CT Scanning Experience and Implications.mp4
✅Session 4 Radiation Safety & SPECT-CT Panel Discussion.mp4
✅Session 4 Radiation Safety & SPECT-CT Radiation Safety in the Age of Theranostics.mp4
✅Session 5 Future Applications Current and Emerging Radiopharmaceuticals in Theranostics.mp4
✅ Session Future Applications Expanding the Practice of Lu177-Based Radiopharmaceutical Therapies From a Tertiary Care Hospital to the Community Opportunities and Challenges.mp4
✅Session 5 Future Applications Hype, Reality, and the Future Potential of AI in Nuclear Medicine.mp4
✅ Session Future Application, PET Imaging’s Impact on Medicine, Research, and Future Options.mp4
Thank you for providing this